The role of C-reactive protein as a risk predictor of coronary atherosclerosis: implications from the JUPITER trial (Q37832997)

24 August 2017

1 reference

title

The role of C-reactive protein as a risk predictor of coronary atherosclerosis: implications from the JUPITER trial (English)

1 reference

24 August 2017

1 reference

Thura T Abd

1

1 reference

24 August 2017

Danny J Eapen

2

1 reference

24 August 2017

Ambareesh Bajpai

3

1 reference

24 August 2017

Abhinav Goyal

4

1 reference

24 August 2017

Allen Dollar

5

1 reference

24 August 2017

Laurence Sperling

6

1 reference

24 August 2017

1 April 2011

1 reference

Current Atherosclerosis Reports

24 August 2017

1 reference

24 August 2017

13

1 reference

24 August 2017

154-161

1 reference

24 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/s11883-011-0164-5

24 August 2017

0 references

cites work

The effect of including C-reactive protein in cardiovascular risk prediction models for women.

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0164-5

C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0164-5

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0164-5

Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0164-5

Should we measure C-reactive protein on earth or just on JUPITER?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0164-5

C-reactive protein and cardiovascular disease: new insights from an old molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0164-5

Acute-phase proteins and other systemic responses to inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0164-5

Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0164-5

Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0164-5

C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0164-5

Lipids, atherosclerosis and CVD risk: is CRP an innocent bystander?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0164-5

C-reactive protein and coronary heart disease: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0164-5

Genetically elevated C-reactive protein and ischemic vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0164-5

C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0164-5

C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0164-5

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0164-5

Use and misuse of the receiver operating characteristic curve in risk prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0164-5

Association of carotid artery intima-media thickness, plaques, and C-reactive protein with future cardiovascular disease and all-cause mortality: the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0164-5

Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0164-5

C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0164-5

C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0164-5

C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0164-5

Assessing the value of risk predictions by using risk stratification tables

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0164-5

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0164-5

C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0164-5

Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0164-5

Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0164-5

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0164-5

From here to JUPITER: identifying new patients for statin therapy using data from the 1999-2004 National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0164-5

Cost-effectiveness of using high-sensitivity C-reactive protein to identify intermediate- and low-cardiovascular-risk individuals for statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0164-5

Cost-effectiveness of statin therapy for vascular event prevention in adults with elevated C-reactive protein: implications of JUPITER.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0164-5

Statin cost-effectiveness in the United States for people at different vascular risk levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0164-5

Comparing impact and cost-effectiveness of primary prevention strategies for lipid-lowering

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0164-5

Optimizing statin treatment for primary prevention of coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0164-5

Another look at the results of the JUPITER trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0164-5

C-Reactive Protein and Prediction of Coronary Heart Disease and Global Vascular Events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0164-5

The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0164-5

C-reactive protein and the acute-phase response

21 January 2018

1 reference

12 December 2020

Comments on 'Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond' by M. J. Pencina et al., Statistics in Medicine (DOI: 10.1002/sim.2929)

1 reference

12 December 2020

Cardiovascular disease risk assessment in older women: can we improve on Framingham? British Women's Heart and Health prospective cohort study.

1 reference

12 December 2020

Binding of human C4 to C-reactive protein-pneumococcal C-polysaccharide complexes during activation of the classical complement pathway

1 reference

12 December 2020

Elevation of C-reactive protein in "active" coronary artery disease

1 reference

12 December 2020

Rosuvastatin in patients with elevated C-reactive protein

1 reference

12 December 2020

C-reactive protein: binding to lipids and lipoproteins

1 reference

12 December 2020

Effect of C-reactive protein on platelet-activating factor-induced platelet aggregation and membrane stabilization

1 reference

12 December 2020

Coronary C-reactive protein distribution: its relation to development of atherosclerosis

1 reference

12 December 2020

10.1007/S11883-011-0164-5

Identifiers

DOI

1 reference

24 August 2017

1 reference